奥曲肽注射液治疗62例重症胰腺炎患者的临床疗效分析

Clinical efficacy of octreotide injection in the treatment of 62 patients with severe pancreatitis

目的观察奥曲肽注射液对重症胰腺炎患者的临床疗效。方法选择2010年6月～2012年3月笔者所在医院收治的62例重症胰腺炎患者,随机分为两组:对照组32例和观察组30例,对照组采用常规治疗方法,观察组在对照组基础上加用奥曲肽注射液。观测并记录治疗后两组患者腹痛显著减轻时间、血尿淀粉酶恢复正常时间、住院时长等指标。结果治疗后观察组患者在腹痛显著减轻时间、血尿淀粉酶恢复正常时间、住院时长方面均明显优于对照组(P<0.05);两组总有效率比较,差异有统计学意义(P<0.05)。结论临床使用奥曲肽注射液治疗重症胰腺炎患者疗效确切,并能显著缩短患者住院时长,值得临床推广。

Objective To investigate clinical efficacy of octreotide injection in the treatment of patients with severe pancreatitis.Methods 62 patients with severe pancreatitis in our hospital from June 2010 to March 2012 were divided into the control group（32）and observation group（30）,the control group with conventional treatment,the observation group on the basis of octreotide injection.The time of abdominal pain relief,recovery of urine amylase,hospital stay were observed.Results After treatment,patients with abdominal pain significantly reduce the time,urine amylase recovery time and hospital length are significantly better than the control group（P 0.05）.The difference of the efficiency between the two groups was statistically significant（P 0.05）.Conclusion Octreotide injection in the treatment of patients with severe pancreatitis have exact efficacy,and can significantly shorten hospitalization,worthy of clinical.